Zachary S. Wallace
Amgen (United States)(US)Harvard University(US)MGH Institute of Health Professions(US)Massachusetts General Hospital(US)ENT and Allergy(US)St Vincent's Clinic(AU)Kensington Health(CA)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, IgG4-Related and Inflammatory Diseases, Vasculitis and related conditions, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19
Most-Cited Works
- → Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry(2020)1,173 cited
- → International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease(2015)1,027 cited
- → The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease(2019)716 cited
- → Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry(2021)684 cited
- → Rituximab for IgG4-related disease: a prospective, open-label trial(2015)684 cited
- → IgG4‐Related Disease: Clinical and Laboratory Features in One Hundred Twenty‐Five Patients(2015)